Nov 26, 2019:
The pharma industry is at the brink of exciting changes that are set to revolutionize the health care industry. Diseases which were once managed using chronic drugs are set to witness a paradigm shift in care through gene therapy. DNA sequencing costs have now become affordable, allowing genome profiling and personalized drug therapy and interventions.
Wearables which were once considered the norm for fitness enthusiasts and the health conscious are now at the tipping point for broader usage. They are sophisticated, interoperable, engaging and with better outcomes. Such devices are being increasingly used to monitor diet, lifestyle and to alert about health conditions like a heart attack, 24 hours before it happens. A smart contact lens has been designed to detect sugar levels from tears and to transmit the information to a wireless device. Treatment plans now include wearables so doctors can better monitor a patient’s progress. This will also help in converting homes into hospitals, lowering anxiety about lapse in patient monitoring but reducing healthcare costs.
Drug developers are utilizing such wearables and AI to improve their R&D in terms of cost and quality. The Pharmaceutical industry has become truly insight driven with better healthcare being the driving force.
Author:
 |
Dr Ayaaz Hussain Khan Global Head, Generics, Navitas Life Sciences |
Click here to read the original post